Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Article number2401126
Pages (from-to)1154-1155
Number of pages2
JournalNew England Journal of Medicine
Volume390
Issue number12
DOIs
Publication statusPublished - 21 Mar 2024
Externally publishedYes

Keywords

  • Humans
  • Glomerulosclerosis, Focal Segmental/drug therapy
  • Irbesartan/therapeutic use
  • Spiro Compounds
  • Sulfonamides

Cite this